Overview

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

Status:
Completed

Trial end date:
2005-07-01

Target enrollment:

Participant gender:

Summary

The current protocol is designed to satisfy the need for a compassionate use treatment protocol as well as for a long-term open label follow-up study.

Phase:

Phase 3

Details

Lead Sponsor:

Mylan Bertek Pharmaceuticals

Treatments:

Apomorphine